<DOC>
	<DOC>NCT00830102</DOC>
	<brief_summary>The primary purpose was to evaluate the efficacy of SKP FlutiForm HFA MDI compared to placebo or fluticasone and formoterol administered concurrently or alone in asthma patients.</brief_summary>
	<brief_title>Single-dose Crossover Study to Compare the Safety and Efficacy of FlutiForm With Fluticasone and Formoterol Concurrently or Alone in Asthma Patients</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Formoterol Fumarate</mesh_term>
	<mesh_term>Fluticasone</mesh_term>
	<criteria>Subjects with documented history of mild to moderate asthma currently taking a stable dose of inhaled corticosteroid Smoking history within the last 12 months No history of respiratory tract infection within 4 weeks No history or evidence of any clinically significant disease or abnormality</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>June 2011</verification_date>
	<keyword>Mild to Moderate Asthma</keyword>
</DOC>